Tag: Ligand Pharmaceuticals

Lemelson Announces 2% Stake in Geospace Technologies Corp

Lemelson Announces 2% Stake in Geospace Technologies Corp

Marlborough, Mass., October 20, 2014—Lemelson Capital Management, a private investment management firm, today announced that it has taken a significant position in shares of Geospace Technologies Corp (NASDAQ:GEOS). Lemelson Capital’s investment in Geospace Technologies, which will be held in the […]

Lemelson Capital Up 60% In Past 12 Months

Lemelson Capital Up 60% In Past 12 Months

Lemelson Capital Management, a private investment management firm, today marked the second anniversary of the launch of its flagship fund, The Amvona Fund, LP which has ranked repeatedly among the world’s top performing hedge funds. The firm also today released […]

Lemelson: Ligand Pharmaceuticals At Risk Of Bankruptcy

Lemelson: Ligand Pharmaceuticals At Risk Of Bankruptcy

Marlborough, Mass., August 14, 2014—Lemelson Capital Management, a private investment management firm, today released a research note and audio interview by the firm’s Chief Investment Officer Emmanuel Lemelson, raising new and escalated concerns about the going concern risk and bankruptcy […]

Lemeson Ups Ligand Pharmaceuticals Inc. (LGND) Short

Lemeson Ups Ligand Pharmaceuticals Inc. (LGND) Short

Lemelson Capital Management, a private investment management firm, today announced that it has further increased its short position in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) and appended with additional concerns its initial June 16, 2014 research report. Today’s appended report can be found […]